Belimumab is a biologic medication used to treat adults with lupus (systemic lupus erythematosus, also called SLE) and lupus nephritis. SLE is caused by your body making antibodies that attack your own cells. Belimumab treats SLE by blocking the cells that make these antibodies, known as B-cells. Belimumab can help suppress an overactive immune system. . .
Drug Class: Disease-Modifying Anti-Rheumatic Drug (DMARD)
Baricitinib
Baricitinib is a Disease-Modifying Anti-Rheumatic Drug (DMARD) used to treat rheumatoid arthritis (RA) by inhibiting an enzyme called Janus kinase (JAK) which would otherwise trigger numerous inflammatory reactions. Baricitinib can help suppress an overactive immune system but can also increase your risk of certain infections.
Apremilast
Apremilast is used to treat inflammatory types of arthritis, such as psoriatic arthritis (PsA). Apremilast blocks phosphodiesterase-4 (PDE-4) which is a molecule that triggers many different inflammatory processes. Apremilast may cause nausea, vomiting and diarrhea. Speak to a healthcare provider if these side effects are intolerable.
Anifrolumab
Anifrolumab is used in addition to standard therapy (oral corticosteroids and/or immunosuppressants and/or antimalarials) for the treatment of adult patients with active, autoantibody positive, systemic lupus erythematosus (SLE). It works by blocking the action of a group of proteins called Type I Interferons (IFN) by binding to a portion of the type I interferon receptor (IFNAR1) thereby. . .
Anakinra
Anakinra is used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA). Anakinra works by blocking interleukin-1 (IL-1) which triggers inflammation in your body. Blocking this can halt the underlying cause of RA and prevent joint damage. Anakinra can help suppress an overactive immune system but can also increase your risk of certain infections.
Adalimumab
Adalimumab is used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), juvenile idiopathic arthritis (JIA), and ankylosing spondylitis (AS). It works by blocking TNF-α which triggers inflammation. It can help suppress an overactive immune system but can also increase your risk of infections. There are biosimilar versions of adalimumab, which are highly similar versions. . .
Abatacept
Abatacept is a medication that treats conditions such as rheumatoid arthritis and psoriatic arthritis by blocking a type of immune cell called a T-cell from damaging your joints. It can help suppress an overactive immune system, but can also increase your risk for certain infections.
